Triptolide palmitate
Triptolide palmitate is the derivative of Triptolide. Triptolide palmitate exhibits cytotoxicity against cancer cell MCF-7 and A549, with IC50 of 7.5 and 6.4 μM. Triptolide palmitate exhibits a half-time T1/2 of 50.4 min in Sprague Dawley rats. Triptolide palmitate can be utilizd as drug carrier[1].
Product Specifications
CAS Number
2126920-51-0
UNSPSC
12352005
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/triptolide-palmitate.html
Purity
99.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@@]12[C@@]34[C@@]5([C@@](C[C@@]1([H])C6=C(C(OC6)=O)CC2)([H])O5)[C@@H]([C@@]7([C@](O7)([H])[C@]3([H])O4)C(C)C)OC(CCCCCCCCCCCCCCC)=O
Molecular Formula
C36H54O7
Molecular Weight
598.81
References & Citations
[1]Fu Z, et al., A kind of triptolide derivative and preparation method thereof and preparation. CN106946975.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CFB (Complement Factor B, C3/C5 Convertase, Glycine-rich beta Glycoprotein, GBG, PBF2, Properdin Factor B, CFB, BF, BFD) (MaxLight 650) discontinued
OASL, CT (59kD 2'-5'-oligoadenylate Synthase-like Protein, p59 OASL, p59OASL, Thyroid Receptor-interacting Protein 14, TR-interacting Protein 14, TRIP-14, TRIP14) (MaxLight 650) discontinued
Recombinant Parvibaculum lavamentivorans Glutamate--tRNA ligase 1 (gltX1)
Recombinant Parvibaculum lavamentivorans Glutamate--tRNA ligase 1 (gltX1)
Recombinant Parvibaculum lavamentivorans Glutamate--tRNA ligase 1 (gltX1)